Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study

Junyan Qian, Mengtao Li, Xiao Zhang, Qian Wang, Jiuliang Zhao, Zhuang Tian, Wei Wei, Xiaoxia Zuo, Miaojia Zhang, Ping Zhu, Shuang Ye, Wei Zhang, Yi Zheng, Wufang Qi, Yang Li, Zhuoli Zhang, Feng Ding, Jieruo Gu, Yi Liu, Yanhong Wang, Xiaofeng Zeng

Source: Eur Respir J, 53 (2) 1800081; 10.1183/13993003.00081-2018
Journal Issue: February
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Junyan Qian, Mengtao Li, Xiao Zhang, Qian Wang, Jiuliang Zhao, Zhuang Tian, Wei Wei, Xiaoxia Zuo, Miaojia Zhang, Ping Zhu, Shuang Ye, Wei Zhang, Yi Zheng, Wufang Qi, Yang Li, Zhuoli Zhang, Feng Ding, Jieruo Gu, Yi Liu, Yanhong Wang, Xiaofeng Zeng. Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study. Eur Respir J, 53 (2) 1800081; 10.1183/13993003.00081-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effectiveness of ²Korargin² in the therapy of pulmonary arterial hypertension in patients with systemic lupus erythematosus
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011

Endothelium dysfunction in systemic lupus erythematosus patients with pulmonary hypertension
Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Year: 2011


Early outcomes of patients with systemic lupus erythematosus and antiphospholipid syndrome after pulmonary endarterectomy
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016


Immunosuppression in systemic lupus erythematosus associated pulmonary arterial hypertension (SLE-APAH): Improvement in exercise and functional capacity
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011


Prevalence of pulmonary hypertension in patients with plasma lupus anticoagulant
Source: Eur Respir J 2006; 28: Suppl. 50, 406s
Year: 2006

Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension
Source: Eur Respir J, 52 (4) 1801745; 10.1183/13993003.01745-2018
Year: 2018



Charactaristics and prognosis of autoimmune antibody-positive patients of idiopathic pulmonary arterial hypertension
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021


Screening for pulmonary arterial hypertension in an unselected prospective systemic sclerosis cohort
Source: Eur Respir J, 49 (5) 1602275; 10.1183/13993003.02275-2016
Year: 2017



Identifying early pulmonary arterial hypertension in patients with systemic sclerosis
Source: Eur Respir J, 51 (4) 1800495; 10.1183/13993003.00495-2018
Year: 2018



Pulmonary arterial hypertension and systemic lupus erythematosus
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009

Predictors of pulmonary artery hypertension in patients with systemic sclerosis
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012


Incidence of pulmonary arterial hypertension related to systemic sclerosis: a 3-year nationwide longitudinal study
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008


Secondary pulmonary hypertension in chronic obstructive pulmonary disease and systemic lupus erythematosus- pathophysiology and treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 59s
Year: 2004

Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening
Source: Eur Respir Rev 2011; 20: 270-276
Year: 2011



Survival of pulmonary arterial hypertension related to systemic sclerosis: a 3-year nationwide longitudinal study
Source: Annual Congress 2008 - Pulmonary vascular medicine
Year: 2008


Survival and prognostic factors in patients with incident systemic sclerosis-associated pulmonary arterial hypertension from the French registry
Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Year: 2011


Systemic inflammation and pulmonary hypertension in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 142s
Year: 2007

Pulmonary hypertension and arterial stiffness in patients with systemic scleroderma
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010

Raynaud phenomenon is correlated with systolic pulmonary arterial pressure in patients with systemic lupus erythematosus
Source: Eur Respir J 2006; 28: Suppl. 50, 827s
Year: 2006

Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis
Source: Eur Respir J, 51 (4) 1701197; 10.1183/13993003.01197-2017
Year: 2018